Professor Wilbert S. Aronow

Professor of Medicine at New York Medical College Director of Cardiology Research at Westchester Medical Center


Wilbert S. Aronow MD is Professor of Medicine and Director of Cardiology Research at Westchester Medical Center and New York Medical College Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 21 books and is author or co-author of 1,718 papers,  212 book chapters in 116 books, 960 commentaries, 50 Letters to the Editor, and 1204 abstracts and is presenter or co-presenter of 1,582 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the ASPC, the AGS (Founding Fellow of Western Section), and the GSA. He has been a member of 185 editorial boards of medical journals, editor-in-chief of 5 journals, co-editor of 3 journals, deputy editor of 1 journal, executive editor of 2 journals, associate editor for 9 journals, and  guest editor for 7 other medical journals, and has reviewed manuscripts for 444  journals. He has received each year from 2001-2017 an outstanding teacher and researcher award from the medical residents and  from 2001-2022 from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College including the 2014 Chancellor’s Research Award and the 2021 excellence in Teaching Dean’s Faculty Award, the F1000 Faculty Member of the Year Award for the Faculty of Cardiovascular Disorders in 2011, and 2013-2021, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, a Distinguished Fellowship Award from the International Academy of Cardiology in July, 2012, and the Expertscape World Expert in Hypertension  Award in May, 2019.  He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure , co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and a coauthor of the 2017 ACC/AHA  guidelines for the management of patients with hypertension. He was a coauthor of a 2015 position paper from the International Lipid Expert Forum. He was a consultant to the American College of Physicians Information and Educational Resource (PIER) on the module of aortic stenosis, a consultant to the American Board of Internal Medicine on hypertension, a member of the Board of Directors of the ASPC, a member of the ACCP Cardiovascular Medicine and Surgery Network Steering Committee, and is a member of the Scientific Executive Committee of the International Academy of Cardiology. He has been a committee member of other professional societies and a consultant to many government agencies. He has mentored 304 cardiology fellows and 669 other trainees plus numerous junior faculty for publications listed on PubMed during his professional career.


Expert content

LBPMC Publications

RSS Aronow WS
  • Atherosclerosis and HIV: Exploring Cardiovascular Risks and Management 2024-07-09
    The advent of antiretroviral therapy has markedly improved the life expectancy of individuals with HIV, leading to a shift in clinical focus from managing opportunistic infections to addressing chronic conditions, such as atherosclerotic cardiovascular disease (ASCVD). Emerging evidence highlights an elevated risk of ASCVD among people living with HIV, characterized by a higher incidence of […]
    Matthew Seplowe
  • Role of the Electrocardiogram for Identifying the Development of Atrial Fibrillation 2024-07-06
    Atrial fibrillation (AF), a prevalent cardiac arrhythmia, is associated with increased morbidity and mortality worldwide. Stroke, the leading cause of serious disability in the United States, is among the important complications of this arrhythmia. Recent studies have demonstrated that certain clinical variables can be useful in the prediction of AF development in the future. The […]
    Sahar Memar Montazerin
  • Managing the Intricacies of Coronary Revascularization: A Close Look at the Complete Versus Culprit-Only Approach and its Implications in Elderly Patients 2024-07-06
    Coronary heart disease is the leading cause of mortality in the United States, and data indicates that 805,000 Americans will face a new or recurrent myocardial infarction (MI) attack every year. Frailty, a conceptual syndrome categorized by a functional decline that occurs with aging, has been linked to adverse health outcomes in cardiovascular disease and […]
    Mahmoud El Hajj
  • Outpatient Continuous Intravenous Inotropy in the Modern Era 2024-07-06
    The use of continuous inotropy in patients with advanced heart failure (HF) has been historically controversial due to the prevailing notion that it will increase mortality. In practice, clinicians have continued to revisit this idea as there remains a lack of treatment options for patients in stage D HF. Clinical trials in the past have […]
    Tzvi Fishkin
  • Transcatheter Intervention for Management of Tricuspid Regurgitation Using TriClip 2024-06-27
    Severe tricuspid regurgitation (TR) is an underrated, common pathology that affects over 70 million individuals worldwide. Traditionally, TR has been managed with diuretic therapies without any significant mortality benefit. The underlying cause of TR can be primary, coming from structural issues with tricuspid valve and more commonly secondary, arising from conditions affecting the right ventricle […]
    Anmol Sharedalal
  • Zalunfiban: A Review of Current Knowledge and Future Applications of an Innovative Antiplatelet Agent 2024-06-26
    Zalunfiban is a novel glycoprotein IIb/IIIa inhibitor currently being tested for its use in the prehospital setting for antiplatelet effect in patients with ST-elevation myocardial infarction. It has shown to be safe and effective in both phase 1 and phase 2 trials and is under investigation in phase 3 trials. In this review, we discuss […]
    Kassidy Veasaw
  • Blood Transfusions in Acute Myocardial Infarctions: A Review 2024-05-30
    Anemia in acute myocardial infarctions has been an area of curiosity, with studies looking into clinical outcomes of blood transfusions in this patient population for decades without consistent evidence in the literature pointing in the direction of liberal or conservative transfusion use. With the recent publication of the MINT (Restrictive or Liberal Transfusion Strategy in […]
    Sreshta Paranji
  • Atrial Fibrillation and Cognitive Disorders 2024-05-30
    The prevalence of atrial fibrillation among older adults is increasing. Research has indicated that atrial fibrillation is linked to cognitive impairment disorders such as Alzheimer and vascular dementia, as well as Parkinson disease. Various mechanisms are believed to be shared between atrial fibrillation and cognitive impairment disorders. The specific pathologies and mechanisms of different cognitive […]
    Maryam Barkhordarian
  • Cardiac Manifestations of Lymphoma: A Review of Primary and Secondary Cardiac Lymphoma 2024-05-30
    Primary cardiac lymphoma (PCL) is a very unique and uncommon disease presentation, with reports in the literature limited to case reports. Most often it is B-cell in origin, predominantly diffuse large B-cell lymphoma. Symptomatic presentation of PCL depends on the location of anatomic involvement, but most often involves the right heart, with presentation consistent with […]
    Aatif Khurshid
  • Cardiovascular Disease and Dementia: Exploring Intersections, Risks, and Therapeutic Challenges 2024-05-24
    This review examines the complex bidirectional relationship between cardiovascular disease and various dementia subtypes, including Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia. Traditional cardiovascular risk factors such as hypertension, coronary artery disease, arrhythmia, and diabetes mellitus are strongly linked to the development of dementia. Emerging evidence indicates that cognitive decline can exacerbate […]
    Lillian Huang
  • Diastolic Dysfunction and Atrial Fibrillation: Recognition, Interplay, and Management 2024-05-23
    Diastolic dysfunction occurs when the left ventricle loses its ability to relax normally, impairing ventricular filling during diastole. This most commonly occurs as a pathological sequela of left ventricular hypertrophy and remodeling due to chronic hypertension and/or age-related sclerotic changes of the aortic valve. This can subsequently deteriorate to diastolic heart failure or heart failure […]
    Somar Hadid
  • Semaglutide in Heart Failure With Preserved Ejection Fraction: Exploring Recent Evidence in Therapeutic Potential for the Obese Population 2024-05-17
    Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent condition, particularly among the aging population in the United States, and is associated with significant challenges due to its complex pathophysiology and limited therapeutic options. Historically, few pharmacological therapies have successfully mitigated HFpEF, making the emergence of effective treatments particularly significant. This review evaluates […]
    Josef Kusayev
  • Bloodless Cardiac Surgery in Jehovah's Witness: A Comprehensive Review 2024-05-17
    This article explores the major challenges and specialized strategies involved in managing cardiovascular surgery patients who are Jehovah's Witnesses and refuse blood transfusions due to their religious beliefs. It delves into preoperative, intraoperative, and postoperative approaches aimed at minimizing blood loss and optimizing patient outcomes while respecting their autonomy. Preoperative measures focus on correcting anemia […]
    Darshil Kumar Maheta
  • Understanding Perioperative Acute Myocardial Ischemia Following Coronary Artery Bypass Grafting 2024-05-16
    Surgical revascularization and coronary artery bypass grafting are often pursued as treatment for obstructive coronary artery disease. Despite trends of increased referrals for complex percutaneous coronary intervention, surgical revascularization often remains the standard of care for patients with multivessel or complex coronary artery disease. Myocardial ischemia during the perioperative and postoperative periods during coronary artery […]
    Ritika Kompella
  • Role of Colchicine in Cardiovascular Disorders 2024-05-16
    Inflammation has played a pivotal role in atherosclerosis and other cardiovascular disorders, prompting the exploration of anti-inflammatory therapies to improve cardiovascular outcomes. Colchicine, a well-established agent in conditions such as gout and familial Mediterranean fever, has emerged as a promising novel anti-inflammatory agent in the realm of cardiovascular diseases. Its ability to target both traditional […]
    Errol Moras
  • Corrigendum to 'present knowledge on direct oral anticoagulant and novel oral anti coagulants and their specific antidotes: A comprehensive review article'. Current problems in cardiology. 2023 Feb 1); Vol 48(2):101483 2024-05-10
    No abstract
    Suman Biswas
  • Goflikicept and Related IL-1 Inhibitors in the Treatment of Recurrent Pericarditis 2024-05-06
    Anticytokine biologics are a promising anti-inflammatory therapy for recurrent pericarditis. Several studies have proved the efficacy and safety of interleukin-1 (IL-1) inhibitors, such as anakinra and rilonacept in patients with recurrent pericarditis. Treatment with goflikicept in a recent phase 2 and 3 trial significantly reduced the pericarditis recurrence rate compared with both the placebo and […]
    Jared M Feldman
  • The role of phosphodiesterase 9A inhibitors in heart failure 2024-05-04
    INTRODUCTION: There are currently limited effective treatments available to improve lusitropy in patients suffering from heart failure with preserved ejection fraction. The role of PDE9A in diastolic dysfunction has been well-studied over recent years, with a special focus on its association with myocardial hypertrophy. Recent insights into PDE9A inhibition have brought to light the potential […]
    Saam Foroshani
  • Intravenous Iron Therapy in Heart Failure Patients With Iron Deficiency: Benefits, Safety, and Guidelines 2024-04-26
    Iron deficiency is a common comorbidity in heart failure (HF) patients, with up to 50% of ambulatory patients with HF affected. Intravenous (IV) iron therapy has emerged as a promising treatment approach for HF patients with concomitant iron deficiency. This review summarizes the current literature on the use of IV iron therapy in HF patients, […]
    Swati Chand
  • Pregnancy-Associated Venous Thromboembolism 2024-04-26
    One of the leading causes of maternal death in the United States is venous thromboembolism (VTE), which is influenced by acquired, genetic, and environmental factors. Pregnancy-associated physiological changes that exhibit the characteristics of Virchow's triad: reduced fibrinolysis, increased coagulation factors, trauma, and venous stasis all raise the risk of VTE. Furthermore, multiple gestations, advanced maternal […]
    Omar Seyam